BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Pfizer Inc. (PFE) Lung Cancer Pill May Double Survival


6/6/2011 8:11:10 AM

An experimental drug called crizotinib sharply increases survival in lung cancer patients with a specific genetic mutation, researchers said Sunday. Although only about 4% of lung cancer patients carry the mutation, that still amounts to about 50,000 people worldwide, experts said. Researchers hope that other new drugs targeted at different mutations will be also developed and that combinations of such targeted drugs will prove even more effective in lung cancer. Lung cancer is the second-most-common form of cancer in the United States and the biggest cancer killer among both men and women, with 371,000 cases diagnosed each year and 159,000 deaths.

Read at AP
Read at Boston Globe
Read at Los Angeles Times


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->